Disease · MONDO_0005921
Comparisons in its trials18
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 18 of 18
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Pyronaridine Artesunate vs Chloroquine: deaths from any cause | 2 of 228 | 0 of 228 | 456 | NCT00440999 | Trial comparisons |
| Pyronaridine Artesunate vs Chloroquine: serious adverse events | 2 of 228 | 0 of 228 | 456 | NCT00440999 | Trial comparisons |
| TQ+CQ vs PQ+CQ: Number of Participants With P. Falciparum | 4 of 166 | 3 of 85 | 251 | NCT02216123 | Trial comparisons |
| TQ+CQ vs PQ+CQ: Number of Participants With Recrudescence | 0 of 166 | 0 of 85 | 251 | NCT02216123 | Trial comparisons |
| TQ+CQ vs PQ+CQ: deaths from any cause | 0 of 166 | 0 of 85 | 251 | NCT02216123 | Trial comparisons |
| TQ+CQ vs PQ+CQ: serious adverse events | 6 of 166 | 1 of 85 | 251 | NCT02216123 | Trial comparisons |
| Artemether-lumefantrine (Coartem™) + Primaquine vs Chloroquine + Primaquine: deaths from any cause | 0 of 84 | 0 of 75 | 159 | NCT04222088 | Trial comparisons |
| Artemether-lumefantrine (Coartem™) + Primaquine vs Chloroquine + Primaquine: serious adverse events | 0 of 84 | 0 of 75 | 159 | NCT04222088 | Trial comparisons |
| Artemether-lumefantrine (Coartem™) + Primaquine vs Chloroquine + Primaquine: Adequate Clinical and Parasitological Response (ACPR) | 74 of 75 | 72 of 74 | 149 | NCT04222088 | Trial comparisons |
| Artemether-lumefantrine (Coartem™) + Primaquine vs Chloroquine + Primaquine: Early Treatment Failure (ETF) | 0 of 75 | 0 of 74 | 149 | NCT04222088 | Trial comparisons |
| Artemether-lumefantrine (Coartem™) + Primaquine vs Chloroquine + Primaquine: Late Clinical Failure (LCF) | 1 of 75 | 0 of 74 | 149 | NCT04222088 | Trial comparisons |
| Artemether-lumefantrine (Coartem™) + Primaquine vs Chloroquine + Primaquine: Late Parasitological Failure (LPF) | 0 of 75 | 2 of 74 | 149 | NCT04222088 | Trial comparisons |
| Cohort 1 Tafenoquine vs Cohort 1-Chloroquine: deaths from any cause | 0 of 46 | 0 of 24 | 70 | NCT01290601 | Trial comparisons |
| Cohort 1 Tafenoquine vs Cohort 1-Chloroquine: serious adverse events | 5 of 46 | 0 of 24 | 70 | NCT01290601 | Trial comparisons |
| Pyronaridine - Artesunate vs Chloroquine: deaths from any cause | 0 of 15 | 0 of 15 | 30 | NCT04368910 | Trial comparisons |
| Pyronaridine - Artesunate vs Chloroquine: serious adverse events | 0 of 15 | 0 of 15 | 30 | NCT04368910 | Trial comparisons |
| DSM265 P. Falciparum vs OZ439 P. Vivax: deaths from any cause | 0 of 8 | 0 of 8 | 16 | NCT02573857 | Trial comparisons |
| DSM265 P. Falciparum vs OZ439 P. Vivax: serious adverse events | 0 of 8 | 0 of 8 | 16 | NCT02573857 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0005921/comparisons